Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

aurora-cannabis-shoots-for-$512m-market:-marijuana-stock-analyst-initiates-coverage-with-neutral

Aurora Cannabis Shoots For $512M Market: Marijuana Stock Analyst Initiates Coverage With Neutral

Jun 28, 2024

Aurora Cannabis ACB, a key player in the global medical marijuana market, stands at a strategic crossroads. Pablo…

Read more
demystifying-aflac:-insights-from-8-analyst-reviews

Demystifying Aflac: Insights From 8 Analyst Reviews

Jun 28, 2024

8 analysts have expressed a variety of opinions on Aflac (NYSE:AFL) over the past quarter, offering a diverse…

Read more
what-4-analyst-ratings-have-to-say-about-ligand-pharmaceuticals

What 4 Analyst Ratings Have To Say About Ligand Pharmaceuticals

Jun 28, 2024

4 analysts have expressed a variety of opinions on Ligand Pharmaceuticals (NASDAQ:LGND) over the past quarter, offering a…

Read more
forecasting-the-future:-6-analyst-projections-for-safehold

Forecasting The Future: 6 Analyst Projections For Safehold

Jun 28, 2024

Across the recent three months, 6 analysts have shared their insights on Safehold (NYSE:SAFE), expressing a variety of…

Read more
a-closer-look-at-11-analyst-recommendations-for-blue-owl-cap

A Closer Look at 11 Analyst Recommendations For Blue Owl Cap

Jun 28, 2024

In the last three months, 11 analysts have published ratings on Blue Owl Cap (NYSE:OWL), offering a diverse…

Read more
what-9-analyst-ratings-have-to-say-about-prudential-financial

What 9 Analyst Ratings Have To Say About Prudential Financial

Jun 28, 2024

Providing a diverse range of perspectives from bullish to bearish, 9 analysts have published ratings on Prudential Financial…

Read more
forecasting-the-future:-11-analyst-projections-for-crinetics-pharmaceuticals

Forecasting The Future: 11 Analyst Projections For Crinetics Pharmaceuticals

Jun 28, 2024

Throughout the last three months, 11 analysts have evaluated Crinetics Pharmaceuticals (NASDAQ:CRNX), offering a diverse set of opinions…

Read more
key-takeaways-from-twist-bioscience-analyst-ratings

Key Takeaways From Twist Bioscience Analyst Ratings

Jun 28, 2024

Analysts’ ratings for Twist Bioscience (NASDAQ:TWST) over the last quarter vary from bullish to bearish, as provided by…

Read more
the-latest-analyst-ratings-for-thermo-fisher-scientific

The Latest Analyst Ratings For Thermo Fisher Scientific

Jun 28, 2024

Thermo Fisher Scientific (NYSE:TMO) has been analyzed by 10 analysts in the last three months, revealing a diverse…

Read more
analyst-scoreboard:-11-ratings-for-array-technologies

Analyst Scoreboard: 11 Ratings For Array Technologies

Jun 28, 2024

Ratings for Array Technologies (NASDAQ:ARRY) were provided by 11 analysts in the past three months, showcasing a mix…

Read more
the-analyst-landscape:-5-takes-on-avantor

The Analyst Landscape: 5 Takes On Avantor

Jun 28, 2024

Across the recent three months, 5 analysts have shared their insights on Avantor (NYSE:AVTR), expressing a variety of…

Read more
a-closer-look-at-5-analyst-recommendations-for-stoke-therapeutics

A Closer Look at 5 Analyst Recommendations For Stoke Therapeutics

Jun 28, 2024

Ratings for Stoke Therapeutics (NASDAQ:STOK) were provided by 5 analysts in the past three months, showcasing a mix…

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 384
  6. 385
  7. 386
  8. 387
  9. 388
  10. 389
  11. 390
  12. ...
  13. 447
  14. »

Posts pagination

Newer posts Page 1 … Page 387 … Page 447 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.